Paid Clinical Trials Paid Clinical Trials > Browse Categories > Most Often Searched > Diabetes > Alaska

Alaska

Alaska

All Categories Most Often Searched » Diabetes » Alaska


  • Efficacy and Safety of BI 10773/BI 1356 Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: BI 10773;   Drug: BI 10773;   Drug: BI 10773;   Drug: linagliptin;   Drug: BI 10773 linagliptin FDC;   Drug: BI 10773 linagliptin FDC;   Drug: high dose BI 10773 placebo;   Drug: high dose BI 10773 placebo;   Drug: high dose BI 10773 placebo;   Drug: low dose BI 10773 placebo;   Drug: low dose BI 10773 placebo;   Drug: low dose BI 10773 placebo;   Drug: linagliptin;   Drug: linagliptin;   Drug: high dose FDC placebo;   Drug: high dose FDC placebo;   Drug: high dose FDC placebo;   Drug: high dose FDC placebo;   Drug: low dose FDC placebo;   Drug: low dose FDC placebo;   Drug: low dose FDC placebo;   Drug: linagliptin placebo;   Drug: linagliptin placebo;   Drug: linagliptin placebo;   Drug: BI 10773;   Drug: BI 10773 high dose;   Drug: BI 10773 low dose
    Sponsors:   Boehringer Ingelheim Pharmaceuticals;   Boehringer Ingelheim Pharmaceuticals;   Eli Lilly and Company
    Recruiting - verified May 2012
  • CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: glimepride placebo;   Drug: linagliptin placebo;   Drug: linagliptin;   Drug: glimepiride
    Sponsors:   Boehringer Ingelheim Pharmaceuticals;   Boehringer Ingelheim Pharmaceuticals;   Eli Lilly and Company
    Recruiting - verified May 2012
  • BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: Placebo BI 10773 low dose;   Drug: Placebo BI 10773 low dose;   Drug: Placebo BI 10773 high dose;   Drug: Placebo BI 10773 high dose;   Drug: BI 10773 low dose;   Drug: BI 10773 high dose
    Sponsors:   Boehringer Ingelheim Pharmaceuticals;   Boehringer Ingelheim Pharmaceuticals;   Eli Lilly and Company
    Recruiting - verified May 2012

Main Menu
Clinical Trial Categories
Clinical Trial Locations